UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.31% |
| 2 | Technology | 9.89% |
| 3 | Financials | 7.42% |
| 4 | Healthcare | 6.84% |
| 5 | Consumer Discretionary | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
VanEck Gold Miners ETF
GDX
$27.3B
| $787M | 0.27% |
26,877,060
+10,184,694
| +61% | +$278M |
|
|
77
CALL
Alibaba
BABA
$274B
| $783M | 0.27% |
3,689,511
-108,904
| -3% | -$20.4M |
|
78
Energy Transfer Partners
ET
$70.4B
| $781M | 0.27% |
60,876,898
-10,966,976
| -15% | -$135M |
|
79
iShares MSCI Emerging Markets ETF
EEM
$31.2B
| $774M | 0.27% |
17,259,793
+4,899,627
| +40% | +$210M |
|
80
iShares Russell 1000 Value ETF
IWD
$81.8B
| $767M | 0.27% |
5,622,396
-108,533
| -2% | -$14.3M |
|
81
Novartis
NVS
$273B
| $765M | 0.27% |
8,083,807
+467,073
| +6% | +$41.9M |
|
82
Union Pacific
UNP
$163B
| $764M | 0.27% |
4,225,587
+43,252
| +1% | +$7.4M |
|
|
MRSH
83
Marsh
MRSH
$81.3B
| $762M | 0.27% |
6,840,852
+103,074
| +2% | +$10.8M |
|
84
Texas Instruments
TXN
$245B
| $752M | 0.26% |
5,859,718
+472,017
| +9% | +$58.3M |
|
85
CALL
Apple
AAPL
$4.91T
| $752M | 0.26% |
10,237,064
+5,721,104
| +127% | +$368M |
|
|
86
VanEck Junior Gold Miners ETF
GDXJ
$8.79B
| $751M | 0.26% |
17,777,788
+15,425,053
| +656% | +$588M |
|
87
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $745M | 0.26% |
16,755,122
+994,649
| +6% | +$42.1M |
|
88
Verizon
VZ
$197B
| $740M | 0.26% |
12,053,702
-157,666
| -1% | -$9.51M |
|
89
Linde
LIN
$217B
| $740M | 0.26% |
3,474,595
-662,064
| -16% | -$133M |
|
90
Amgen
AMGN
$220B
| $727M | 0.25% |
3,014,125
+251,813
| +9% | +$55.5M |
|
91
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4B
| $704M | 0.24% |
7,425,975
+2,813,025
| +61% | +$244M |
|
92
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.8B
| $698M | 0.24% |
6,871,473
-365,815
| -5% | -$37.2M |
|
93
Lowe's Companies
LOW
$106B
| $697M | 0.24% |
5,816,825
+180,099
| +3% | +$20.6M |
|
94
VF Corp
VFC
$5.25B
| $693M | 0.24% |
6,955,092
+503,673
| +8% | +$45.1M |
|
95
PUT
State Street Financial Select Sector SPDR ETF
XLF
$52.2B
| $688M | 0.24% |
22,347,800
-5,364,000
| -19% | -$157M |
|
96
ExxonMobil
XOM
$675B
| $680M | 0.24% |
9,750,986
+608,455
| +7% | +$42.1M |
|
|
97
CALL
iShares MSCI Emerging Markets ETF
EEM
$31.2B
| $662M | 0.23% |
14,748,400
-6,175,800
| -30% | -$265M |
|
98
Starbucks
SBUX
$106B
| $657M | 0.23% |
7,473,148
+1,201,812
| +19% | +$102M |
|
99
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.9B
| $655M | 0.23% |
5,714,240
+93,036
| +2% | +$10.5M |
|
100
Bristol-Myers Squibb
BMY
$125B
| $652M | 0.23% |
10,163,249
+3,538,088
| +53% | +$203M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 807 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.